ASSET | DATE | % RETURN |
---|---|---|
NioCorp Developments Ltd Common Stock (NB) | 3/1/2023 - 5/30/2023 | 585,455.56% |
Corvus Pharmaceuticals (CRVS) | 3/1/2023 - 5/30/2023 | 317.57% |
P3 Health Partners (PIII) | 3/1/2023 - 5/30/2023 | 245.9% |
American Coastal Insurance (ACIC) | 3/1/2023 - 5/30/2023 | 171.04% |
Bit Digital (BTBT) | 3/1/2023 - 5/30/2023 | 155.47% |
Aquestive Therapeutics (AQST) | 3/1/2023 - 5/30/2023 | 154.54% |
Arlo Technologies (ARLO) | 3/1/2023 - 5/30/2023 | 154.21% |
Pulse Biosciences (PLSE) | 3/1/2023 - 5/30/2023 | 126.14% |
Y mAbs Therapeutics (YMAB) | 3/1/2023 - 5/30/2023 | 116.75% |
Ads Tec Energy (ADSE) | 3/1/2023 - 5/30/2023 | 113.07% |
Jiayin (JFIN) | 3/1/2023 - 5/30/2023 | 108.11% |
Evolv Technologies (EVLV) | 3/1/2023 - 5/30/2023 | 104% |
Verastem (VSTM) | 3/1/2023 - 5/30/2023 | 100.12% |
Xeris Pharmaceuticals (XERS) | 3/1/2023 - 5/30/2023 | 88.97% |
Eos Energy Enterprises (EOSEW) | 3/1/2023 - 5/30/2023 | 87.85% |
Rxsight (RXST) | 3/1/2023 - 5/30/2023 | 83.52% |
WW International, Inc Common Stock (WW) | 3/1/2023 - 5/30/2023 | 82.29% |
Crawford (CRD.A) | 3/1/2023 - 5/30/2023 | 78.35% |
Kopin (KOPN) | 3/1/2023 - 5/30/2023 | 76.52% |
SEALSQ (LAES) | 3/1/2023 - 5/30/2023 | 74.53% |
Eyepoint Pharmaceuticals (EYPT) | 3/1/2023 - 5/30/2023 | 73.81% |
ECARX Holdings Inc Class A Ordinary shares (ECX) | 3/1/2023 - 5/30/2023 | 72.51% |
Integral Ad Science Holding LLC (IAS) | 3/1/2023 - 5/30/2023 | 71.39% |
Preformed Line Products (PLPC) | 3/1/2023 - 5/30/2023 | 70.59% |
Microvision (MVIS) | 3/1/2023 - 5/30/2023 | 68.94% |